UPC (Universe Pharmaceuticals Inc. Class A Ordinary Shares) Stock Analysis - AI Report

Universe Pharmaceuticals Inc. Class A Ordinary Shares (UPC) is a publicly traded Healthcare sector company. As of May 21, 2026, UPC trades at $2.76 with a market cap of $1.45M and a P/E ratio of 0.00. UPC moved +0.00% today. Year to date, UPC is -33.99%; over the trailing twelve months it is -55.22%. Its 52-week range spans $2.00 to $600.00. Rallies surfaces UPC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the AI research view on UPC?

Rallies AI research for UPC combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.

UPC Key Metrics

Key financial metrics for UPC
MetricValue
Price$2.76
Market Cap$1.45M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.33%
52-Week High$600.00
52-Week Low$2.00
Volume3
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest UPC News

UPC Analyst Consensus

UPC analyst coverage data. Average price target: $0.00.

Common questions about UPC

What is the AI research view on UPC?
Rallies AI research for UPC combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for UPC?
Rallies AI research for UPC combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is UPC research on Rallies investment advice?
No. Rallies provides research, data, and educational context for UPC. It does not provide personalized investment advice.
UPC

UPC